Improving care for patients with diabetic kidney disease during hospital transitions
Transitions of care program to make guideline-based recommendations actionable for patients with diabetic kidney disease (TOGA-DKD)
This study is looking to help people with diabetic kidney disease by making sure they get the right medications and support when they leave the hospital, especially for those who might need extra help, so they can stay healthier at home.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10869841 on NIH RePORTER |
What this research studies
This research focuses on enhancing the care of patients with diabetic kidney disease (DKD) during their transition from hospital to home. It aims to identify high-risk patients while they are hospitalized and connect them with a pharmacist-led program that ensures they receive the necessary medications and follow-up care after discharge. By addressing the challenges of medication adherence and care coordination, the program seeks to improve health outcomes for these patients, particularly those from underserved communities. The approach leverages the expertise of pharmacists to facilitate better management of DKD and its complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients hospitalized with high-risk diabetic kidney disease who may benefit from enhanced medication management and care coordination.
Not a fit: Patients with diabetic kidney disease who are not hospitalized or those who do not require medication adjustments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the health outcomes and quality of life for patients with diabetic kidney disease.
How similar studies have performed: Previous research has shown that pharmacist-led interventions during hospital transitions can improve medication adherence and health outcomes, indicating a promising approach.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Di Palo, Katherine E — Albert Einstein College of Medicine
- Study coordinator: Di Palo, Katherine E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.